{"title":"Circulating fibrocyte levels correlate with left ventricular mass in middle-aged healthy adults without hypertension","authors":"Daniel S. Feuer , Borna Mehrad , Ellen C. Keeley","doi":"10.1016/j.ahjo.2024.100442","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Fibrocytes, circulating bone-marrow derived cells that differentiate into fibroblasts and myofibroblasts, are a major source of hypertensive arterial fibrosis and correlate with left ventricular (LV) mass in subjects with hypertension. We tested whether circulating fibrocytes levels correlate with LV mass in middle-aged adults without hypertension.</p></div><div><h3>Methods</h3><p>We measured peripheral blood fibrocyte levels and their activated phenotypes in 13 middle-aged, non-hypertensive adults and performed cardiac magnetic resonance imaging to assess LV mass.</p></div><div><h3>Results</h3><p>There was a strong correlation between total fibrocyte levels (CD45 + Col1+) and LV mass index (<em>r</em> = 0.71, <em>p</em> = 0.006), as well as fibrocyte subsets expressing the chemokine markers CCR2 (<em>r</em> = 0.60, <em>p</em> = 0.032), CCR5 (<em>r</em> = 0.62, <em>p</em> = 0.029), CCR7 (<em>r</em> = 0.60, <em>p</em> = 0.034), co-expression of CXCR4 and CCR2 (<em>r</em> = 0.62, p = 0.029), α-SMA+ (<em>r</em> = 0.57, <em>p</em> = 0.044), CD133 (<em>r</em> = 0.59, <em>p</em> = 0.036), and pSTAT6 (<em>r</em> = 0.64, <em>p</em> = 0.032).</p></div><div><h3>Conclusions</h3><p>Circulating fibrocytes are associated with LV mass index in middle-aged, non-hypertensive adults and may be a harbinger for the development of hypertension.</p></div>","PeriodicalId":72158,"journal":{"name":"American heart journal plus : cardiology research and practice","volume":"45 ","pages":"Article 100442"},"PeriodicalIF":1.3000,"publicationDate":"2024-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666602224000855/pdfft?md5=2dd7c26ff9c185edc2245da1dfb10ae9&pid=1-s2.0-S2666602224000855-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American heart journal plus : cardiology research and practice","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666602224000855","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Fibrocytes, circulating bone-marrow derived cells that differentiate into fibroblasts and myofibroblasts, are a major source of hypertensive arterial fibrosis and correlate with left ventricular (LV) mass in subjects with hypertension. We tested whether circulating fibrocytes levels correlate with LV mass in middle-aged adults without hypertension.
Methods
We measured peripheral blood fibrocyte levels and their activated phenotypes in 13 middle-aged, non-hypertensive adults and performed cardiac magnetic resonance imaging to assess LV mass.
Results
There was a strong correlation between total fibrocyte levels (CD45 + Col1+) and LV mass index (r = 0.71, p = 0.006), as well as fibrocyte subsets expressing the chemokine markers CCR2 (r = 0.60, p = 0.032), CCR5 (r = 0.62, p = 0.029), CCR7 (r = 0.60, p = 0.034), co-expression of CXCR4 and CCR2 (r = 0.62, p = 0.029), α-SMA+ (r = 0.57, p = 0.044), CD133 (r = 0.59, p = 0.036), and pSTAT6 (r = 0.64, p = 0.032).
Conclusions
Circulating fibrocytes are associated with LV mass index in middle-aged, non-hypertensive adults and may be a harbinger for the development of hypertension.